KRAS mutated lung adenocarcinoma responds to pan-ERBB and Aurora kinase inhibitors. [PDF]
Uras IZ +9 more
europepmc +1 more source
Gastrin-Releasing Peptide Receptors Stimulate MAPK-Mediated Growth of Lung Cancer Cells by Transactivating HER4 in a Neuregulin-1, MAP Kinase-Dependent Manner Requiring Activation of the ROS-System. [PDF]
Moody TW +4 more
europepmc +1 more source
Systemic angiogenic protein changes following propranolol therapy in infantile hemangioma: a multi-target perspective. [PDF]
Liang L +5 more
europepmc +1 more source
Cardiotoxic Effects of Osimertinib Compared to Other EGFR Inhibitors: A Systematic Review and Meta-Analysis. [PDF]
Garcia A +8 more
europepmc +1 more source
Targeting HER2-Positive HCC1954 Breast Cancer Cells by Novel Thiazole-Dihydrobenzisoxazoles: In-Depth Design, Synthesis and Initial <i>In Vitro</i> Study. [PDF]
Piven YA +8 more
europepmc +1 more source
HER2 expression and <i>HER2</i> gene amplification in thymic epithelial tumors: a narrative review. [PDF]
Agrafiotis AC +7 more
europepmc +1 more source
Targeted next-generation sequencing reveals genomic differences between male and female breast cancer. [PDF]
Zhu J +6 more
europepmc +1 more source
The future of urothelial carcinoma: a 2024-2025 update of early-phase trials of novel therapeutic agents. [PDF]
Lee YHA, Wong CM, Liu AQ, Teoh JY.
europepmc +1 more source
Phosphoproteomic analysis reveals the diversity of signaling behind ErbB-inhibitor-induced phenotypes. [PDF]
Vaparanta K +10 more
europepmc +1 more source

